The tachosil market research report is one of a series of new reports that provides tachosil market statistics, including the tachosil industry global market size, regional shares, competitors with the tachosil market share, detailed tachosil market segments, market trends, and opportunities, and any further data you may need to thrive in the tachosil industry. This tachosil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The growth in the forecast period can be attributed to increasing heart failures, rising clinical trials, rising healthcare awareness, and a growing geriatric population and growing government initiatives. Major trends in the forecast period include advancements in bioengineered materials, enhanced customization for specific surgical needs, integration of smart technology, and minimally invasive surgical techniques.
The tachosil market is expected to experience significant growth due to the rapid increase in surgical procedures. Surgical operations are performed by trained surgeons to address medical issues, diseases, or bodily injuries. Factors such as the rising prevalence of chronic diseases, advancements in medical technology, and the growing demand for minimally invasive procedures are driving this growth. TachoSil is used in these surgeries to provide effective hemostasis and tissue sealing, reducing complications and improving surgical outcomes. For example, the International Society of Aesthetic Plastic Surgery reported that in 2022, around 14.9 million surgical procedures were conducted globally, and this number rose to 15.8 million in 2023, showing a year-over-year increase in surgical activity. The continued growth in surgical procedures is likely to drive the expansion of the tachosil market.
The increasing number of accidents is also expected to contribute to the market's growth. Accidents are unintended events that cause harm, injuries, or damage, often as a result of human behavior, environmental factors, or mechanical issues. Factors such as higher vehicle usage, distracted driving, and insufficient road safety measures have led to more accidents. TachoSil is used during surgical treatments of accident-related injuries to control bleeding and support tissue sealing. For instance, in May 2024, Transport Canada reported a 6% increase in motor vehicle fatalities in 2022 compared to 2021, with 1,931 deaths. The rising number of accidents is therefore a key driver for the growth of the tachosil market.
In July 2024, Corza Medical, a U.S.-based producer of surgical technologies, acquired Takeda's tachoSil manufacturing operations for an undisclosed sum. This acquisition allows Corza Medical to enhance its production capabilities, streamline its supply chains, and improve service to customers worldwide. The move is anticipated to increase manufacturing capacity and facilitate the introduction of new products within Corza's biosurgery business. Takeda Pharmaceutical Company, a Japanese pharmaceutical firm, was previously responsible for manufacturing tachoSil.
The key company operating in the tachosil market is Corza Medical.
North America was the largest region in the tachosil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tachosil report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tachosil market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tachosil is a surgical hemostatic patch designed to control bleeding and promote tissue sealing during surgical procedures. Composed of a collagen matrix and fibrinogen, it works by adhering to the tissue, facilitating clot formation, and improving hemostasis. Its primary goal is to reduce blood loss and support tissue healing in a variety of surgical settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for Tachosil include cardiovascular surgery, orthopedic surgery, general surgery, transplant surgery, and neurosurgery. Cardiovascular surgery involves the repair, replacement, or reconstruction of heart and blood vessel structures to address conditions such as heart disease, valve disorders, and arterial blockages. Tachosil is available in both liquid and patch formulations and is distributed through various channels, including hospitals, specialty clinics, and ambulatory surgical centers.
The tachosil market consists of sales of surgical adhesion barriers, wound care products, and hemostatic agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to increasing heart failures, rising clinical trials, rising healthcare awareness, and a growing geriatric population and growing government initiatives. Major trends in the forecast period include advancements in bioengineered materials, enhanced customization for specific surgical needs, integration of smart technology, and minimally invasive surgical techniques.
The tachosil market is expected to experience significant growth due to the rapid increase in surgical procedures. Surgical operations are performed by trained surgeons to address medical issues, diseases, or bodily injuries. Factors such as the rising prevalence of chronic diseases, advancements in medical technology, and the growing demand for minimally invasive procedures are driving this growth. TachoSil is used in these surgeries to provide effective hemostasis and tissue sealing, reducing complications and improving surgical outcomes. For example, the International Society of Aesthetic Plastic Surgery reported that in 2022, around 14.9 million surgical procedures were conducted globally, and this number rose to 15.8 million in 2023, showing a year-over-year increase in surgical activity. The continued growth in surgical procedures is likely to drive the expansion of the tachosil market.
The increasing number of accidents is also expected to contribute to the market's growth. Accidents are unintended events that cause harm, injuries, or damage, often as a result of human behavior, environmental factors, or mechanical issues. Factors such as higher vehicle usage, distracted driving, and insufficient road safety measures have led to more accidents. TachoSil is used during surgical treatments of accident-related injuries to control bleeding and support tissue sealing. For instance, in May 2024, Transport Canada reported a 6% increase in motor vehicle fatalities in 2022 compared to 2021, with 1,931 deaths. The rising number of accidents is therefore a key driver for the growth of the tachosil market.
In July 2024, Corza Medical, a U.S.-based producer of surgical technologies, acquired Takeda's tachoSil manufacturing operations for an undisclosed sum. This acquisition allows Corza Medical to enhance its production capabilities, streamline its supply chains, and improve service to customers worldwide. The move is anticipated to increase manufacturing capacity and facilitate the introduction of new products within Corza's biosurgery business. Takeda Pharmaceutical Company, a Japanese pharmaceutical firm, was previously responsible for manufacturing tachoSil.
The key company operating in the tachosil market is Corza Medical.
North America was the largest region in the tachosil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tachosil report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tachosil market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tachosil is a surgical hemostatic patch designed to control bleeding and promote tissue sealing during surgical procedures. Composed of a collagen matrix and fibrinogen, it works by adhering to the tissue, facilitating clot formation, and improving hemostasis. Its primary goal is to reduce blood loss and support tissue healing in a variety of surgical settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for Tachosil include cardiovascular surgery, orthopedic surgery, general surgery, transplant surgery, and neurosurgery. Cardiovascular surgery involves the repair, replacement, or reconstruction of heart and blood vessel structures to address conditions such as heart disease, valve disorders, and arterial blockages. Tachosil is available in both liquid and patch formulations and is distributed through various channels, including hospitals, specialty clinics, and ambulatory surgical centers.
The tachosil market consists of sales of surgical adhesion barriers, wound care products, and hemostatic agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Tachosil Market Characteristics4. Tachosil Market Trends And Strategies5. Tachosil Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market7. Global Tachosil Pricing Analysis & Forecasts30. Global Tachosil Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Tachosil Market32. Recent Developments In The Tachosil Market
3. Tachosil Market Biologic Drug Characteristics
6. Global Tachosil Growth Analysis And Strategic Analysis Framework
8. Tachosil Market Segmentation
9. Global Tachosil Epidemiology Of Clinical Indications
10. Tachosil Market Regional And Country Analysis
11. Asia-Pacific Tachosil Market
12. China Tachosil Market
13. India Tachosil Market
14. Japan Tachosil Market
15. Australia Tachosil Market
16. South Korea Tachosil Market
17. Western Europe Tachosil Market
18. UK Tachosil Market
19. Germany Tachosil Market
20. France Tachosil Market
21. Eastern Europe Tachosil Market
22. North America Tachosil Market
23. USA Tachosil Market
24. Canada Tachosil Market
25. South America Tachosil Market
26. Middle East Tachosil Market
27. Africa Tachosil Market
28. Tachosil Market Competitive Landscape And Company Profiles
29. Global Tachosil Market Pipeline Analysis
33. Tachosil Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Tachosil Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on tachosil market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for tachosil ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tachosil market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Indication: Cardiovascular Surgery; Orthopedic Surgery; General Surgery; Transplant Surgery; Neurosurgery2) By Formulation: Liquid Formulations; Patch Formulations
3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers
Key Companies Profiled: Corza Medical
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Corza Medical
